CARISMA THERAPEUTICS INC lost $1.46 per diluted share in fiscal year 2024. This represents an increase of 43.6% from the prior fiscal year. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to $0.20 per diluted share. The table below carries 13 fiscal years, from 2012 to 2024, and the quarters CARISMA THERAPEUTICS INC has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
What was CARISMA THERAPEUTICS INC's diluted earnings per share in fiscal year 2024?
CARISMA THERAPEUTICS INC lost $1.46 per diluted share in fiscal year 2024.
How fast is CARISMA THERAPEUTICS INC's diluted earnings per share growing?
CARISMA THERAPEUTICS INC (CARM) diluted earnings per share rose by 43.6% year over year, from -$2.59 to -$1.46 in fiscal year 2024.
What is CARISMA THERAPEUTICS INC's diluted earnings per share over the last twelve months?
CARISMA THERAPEUTICS INC (CARM) reported $0.20 per diluted share over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
What was CARISMA THERAPEUTICS INC's diluted earnings per share in the most recent quarter?
CARISMA THERAPEUTICS INC (CARM) reported $1.07 in diluted earnings per share in Q3 2025. This represents an increase of 445.2% from the same quarter a year earlier.
What does diluted earnings per share mean on a financial statement?
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what CARISMA THERAPEUTICS INC (CARM) reported on that line in every period on record.
